Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 101kWORD 17k
8 October 2018
E-004200/2018(ASW)
Answer given by Mr Andriukaitis on behalf of the European Commission
Question reference: E-004200/2018

The Commission is aware of the new technologies intended to produce laboratory-grown meat (‘cultured meat’) using cell cultures.

Article 3(2)(a)(vi) of Regulation (EU) No 2015/2283(1) on novel foods stipulates that food consisting of, isolated from, or produced from a cell culture or tissue culture from animals, plants, micro-organisms, fungi or algae is considered one of the novel food categories listed in the regulation.

Cultured meat may fall in this category. In such case, it would require a pre-market authorisation which would include a safety assessment performed by the European Food Safety Authority (EFSA).

The Novel Food Regulation contains provisions for the safety assessment of such foods before they are placed on the market and for specific labelling requirements to ensure a high level of health protection and consumer information about specific characteristic or food property.

In addition, the Commission may also, for safety reasons, and taking into account the opinion of EFSA, impose post-market monitoring requirements for novel foods.

No application for the authorisation of in-vitro meat has been received so far in the context of novel food.

(1)Regulation (EU) 2015/2283 of 25 November 2015 on novel foods. OJ L327, 11.12.2015, p. 1.

Last updated: 8 October 2018Legal notice - Privacy policy